Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Booz Allen Hamilton Holding Corporation (BAH) Price & Performance

ADMA Biologics IncTrade
Booz Allen Hamilton Holding CorporationTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Booz Allen Hamilton Holding Corporation — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Booz Allen Hamilton Holding Corporation trades at $78.21 (market cap $9.45B). The key difference: Booz Allen Hamilton Holding Corporation is far larger — about 4.3× ADMA Biologics Inc's market cap, and Booz Allen Hamilton Holding Corporation pays a 3% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.

ADMABAH
Market Cap
$2.22B$9.45B
Sector
HealthIndustrials
52-Week High
$20.38$111.63
52-Week Low
$7.60$59.71
Enterprise Value
$2.29B$13.07B
Dividend Yield
3%

Returns comparison

Trailing returns across standard periods

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Booz Allen Hamilton Holding Corporation

Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.

Read more on BAH